View Post

Norwalk Hospital reports positive results with breast cancer clinical trials

In Clinical Trials by Barbara Jacoby

By: Kevin Zimmerman From: westfaironline.com Four cutting-edge breast cancer clinical trials recently launched at Norwalk Hospital’s C. Anthony and Jean Whittingham Cancer Center are giving hope to patients diagnosed with triple negative breast cancer, an aggressive form of the disease that cannot be treated with hormone therapies or other cancer-fighting drugs. “We started about six months ago,” said Dr. Linda …

View Post

Advanced breast cancer patients can benefit from immunotherapy-chemotherapy combination

In Clinical Trials by Barbara Jacoby

Source: upmc.com From: news-medical.net Patients with an aggressive form of advanced breast cancer can benefit from immunotherapy when used in combination with chemotherapy as first-line treatment, according to the results of a large international Phase III clinical trial published today in the New England Journal of Medicine and led by a researcher at the UPMC Hillman Cancer Center and the …

View Post

Immunotherapy trial offers new hope for people with aggressive breast cancer

In Clinical Trials by Barbara Jacoby

Source: qmul.ac.uk From: news-medical.net There is new hope for people with an aggressive type of breast cancer, as an immunotherapy trial shows for the first time that lives can be extended in people with triple-negative breast cancer. New research led by Queen Mary University of London and St Bartholomew’s Hospital has shown that by using a combination of immunotherapy and …

View Post

FREE Immunotherapy Patient Summit – Houston, Sat, December 8, 2018

In Clinical Trials by Barbara Jacoby

From: CANCER RESEARCH INSTITUTE Date and Time:  Sat, December 8, 2018 – 10:00 AM – 3:30 PM PDT Hosted at MD Anderson Cancer Center Dan L. Duncan Cancer Prevention Building, (CPB) – 8th Floor Conference Center 1155 Pressler Street Houston, TX 77030 Learn about the basics of cancer immunotherapy, a highly promising new approach to cancer treatment. Medical experts along with …

View Post

9 things to know about CAR T-cell therapy

In Clinical Trials by Barbara Jacoby

By: Cynthia DeMarco From: mdanderson.org CAR T-cell therapy is a new type of cancer treatment offered at MD Anderson through clinical trials and FDA-approved standard of care cell therapy products. But what exactly is CAR T-cell therapy? And who should consider it? We spoke with Sattva Neelapu, M.D., to learn more. Here’s what he had to say. Let’s start with the …

View Post

Clinical Cancer Research Article Describes Opportunity to Use Imipridones for Brain Tumors

In Clinical Trials by Barbara Jacoby

Oncoceutics, Inc. announced the publication of a scientific research article in the journal Clinical Cancer Research that demonstrates utility for the company’s imipridone portfolio of compounds in neuro-oncology. Oncoceutics developed this portfolio of chemical compounds that target G protein-coupled receptors (GPCRs) using the unique core chemical structure of the company’s lead compound ONC201. The article identifies several opportunities to use …

My doctor has recommended that I consider a breast cancer clinical trial, but …

In Clinical Trials by Barbara Jacoby

Sponsored by: NYU Winthrop Hospital From: liherald.com Douglas Marks, MD and Nina D’Abreo, MD …the idea of receiving a treatment that is not yet approved makes me nervous. I thought clinical trials were for patients with no further treatment options? A: Dr. Douglas Marks: Great question. Medical oncology clinical trials can involve enhanced diagnostic testing, medical treatments and lifestyle interventions. …

Western Connecticut Health Network Site Launches Breast Cancer Clinical Trials through Collaboration with Memorial Sloan Kettering Cancer Center

In Clinical Trials by Barbara Jacoby

As part of a pioneering cancer-care collaboration between Norwalk Hospital and Memorial Sloan Kettering Cancer Center, clinical trials studying new breast cancer therapies are now open in Fairfield County. Four cutting-edge breast cancer clinical trials have launched at Norwalk Hospital, part of the Western Connecticut Health Network. The breast cancer clinical trials are an extension of Memorial Sloan Kettering Cancer …

First In Class Immunostimulating Anticancer Agent able to Directly Inhibit Tumor Signaling and Kill Tumor Cells, is in Clinical Trial for Glioblastoma and Melanoma Metastatic to the Brain

In Clinical Trials by Barbara Jacoby

Small molecule lead drug candidate blocks a critical target for tumors and crosses the blood brain barrier; begins first brain cancer patient dosing in clinical trial at MD Anderson Cancer In the ongoing challenge to combat the almost always deadly brain cancers, namely Glioblastoma and melanoma metastasized to the brain, the pharmaceutical company Moleculin Biotech, Inc., (Nasdaq: MBRX) has initiated …